On this page
Bronchiectasis has two possible schedular paths in 38 CFR § 4.97, Diagnostic Code 6601. VA can rate the disease through the DC 6601 infection-and-sputum criteria, or rate pulmonary impairment as chronic bronchitis under DC 6600.
The code also defines an incapacitating episode precisely: it requires bed rest and treatment by a physician. Antibiotics appear in several percentage criteria, but antibiotic use is not part of that episode definition.
TL;DR
- DC 6601 provides 10, 30, 60, and 100 percent levels.
- The infection path considers total annual duration of incapacitating infection episodes, cough, sputum, hemoptysis, weight loss, and antibiotic treatment.
- An incapacitating episode requires bed rest and treatment by a physician.
- Antibiotic frequency and duration are separate tier-specific facts.
- VA may instead rate pulmonary impairment as chronic bronchitis under DC 6600.
- Section 4.96 generally prevents stacking bronchiectasis with another listed respiratory rating and calls for one predominant evaluation.
- Bronchiectasis is a chronic disease listed in § 3.309(a), with a possible one-year presumption when the service and timing requirements in § 3.307 are met.
- Bronchiectasis is not listed as a PACT Act toxic-exposure presumptive disease.
The DC 6601 Rating Criteria
10 percent
Intermittent productive cough with acute infection requiring a course of antibiotics at least twice per year.
30 percent
Either:
- incapacitating infection episodes totaling two to four weeks per year; or
- daily productive cough with sputum that is sometimes purulent or blood-tinged and requires prolonged antibiotic use, lasting four to six weeks, more than twice per year.
60 percent
Either:
- incapacitating infection episodes totaling four to six weeks per year; or
- near-constant cough with purulent sputum associated with anorexia, weight loss, and frank hemoptysis, requiring antibiotic use almost continuously.
100 percent
Incapacitating infection episodes totaling at least six weeks per year.
The annual duration is cumulative. Preserve the start and end dates of each qualifying episode rather than reporting only the number of infections.
What Counts as an Incapacitating Episode
DC 6601's note says an incapacitating episode is one requiring bed rest and treatment by a physician. Both elements matter. Self-directed rest at home without physician treatment does not meet that definition, and a routine appointment without required bed rest does not establish it either.
Antibiotics should be documented separately because they determine other DC 6601 paths:
- at least two courses per year at 10 percent;
- prolonged four-to-six-week courses more than twice per year on the 30-percent sputum path; and
- almost continuous use on the 60-percent severe-symptom path.
A good log records the infection dates, physician, bed-rest instruction, antibiotic name and duration, sputum findings, hemoptysis, weight change, and total incapacitating days.
The Alternative DC 6600 Route
DC 6601 also says VA may rate according to pulmonary impairment as chronic bronchitis under DC 6600. That path uses FEV-1, FEV-1/FVC, DLCO (SB), exercise capacity, and severe findings such as oxygen therapy or pulmonary hypertension.
When VA uses the DC 6600 path, the PFT application rules in 38 CFR § 4.96 matter. Those rules address post-bronchodilator values, missing DLCO, conflicting PFT results, and circumstances in which severe non-PFT findings control.
The decision should identify which path describes the predominant disability and why it produces the proper evaluation. A claimant should submit both the infection record and complete PFT report when either could be more favorable.
Why Respiratory Ratings Usually Do Not Stack
Section 4.96(a) generally prohibits combining ratings under DCs 6600 through 6817 and 6822 through 6847. VA assigns one evaluation under the code reflecting the predominant disability, with possible elevation to the next level when overall severity warrants it.
That rule matters when the record also lists chronic bronchitis, COPD, asthma, or constrictive bronchiolitis. Coexisting diagnoses and symptoms remain evidence, but overlapping respiratory impairment is not normally paid as multiple schedular ratings.
The One-Year Chronic-Disease Presumption
Bronchiectasis appears in the chronic-disease list in 38 CFR § 3.309(a). Under § 3.307(a), the ordinary chronic-disease presumption generally requires at least 90 days of qualifying continuous service and manifestation to a degree of 10 percent or more within one year after separation.
For bronchiectasis, the 10-percent DC 6601 criterion can help frame what “compensable degree” means, but a clinician still needs to identify the early disease. Repeated cough or infections within the year are not automatically bronchiectasis without competent medical evidence tying those manifestations to the later diagnosis.
This one-year route is separate from the PACT Act. Bronchiectasis is not listed in 38 U.S.C. § 1120 as a toxic-exposure presumptive disease.
Direct and Secondary Service Connection
Direct service connection under 38 CFR § 3.303 may be supported by documented in-service pneumonia or severe respiratory infections followed by competent medical evidence linking that history to permanent airway damage. A claimed airborne-hazard route also needs a case-specific medical nexus when no statutory presumption applies.
Secondary service connection under 38 CFR § 3.310 requires medical evidence that a service-connected disease or treatment caused or aggravated the bronchiectasis. A shared respiratory diagnosis or overlapping symptoms do not establish that relationship by themselves.
What to Preserve
- high-resolution CT and the clinician's diagnosis;
- sputum and hemoptysis findings;
- each infection's dates and treatment records;
- physician-prescribed bed rest;
- antibiotic name, course length, and annual frequency;
- weight and anorexia records when claimed;
- complete pre- and post-bronchodilator PFT reports;
- records from the first post-service year when the chronic presumption may apply; and
- a medical opinion for any direct-exposure or secondary theory.
Common Failure Modes
- Treating every antibiotic course as an incapacitating episode.
- Reporting the number of infections without total annual duration.
- Omitting the physician bed-rest instruction.
- Ignoring the alternative DC 6600 path.
- Adding overlapping respiratory percentages despite § 4.96.
- Saying no presumption covers bronchiectasis and missing §§ 3.307 and 3.309.
- Calling bronchiectasis a PACT Act presumptive condition.
Bottom Line
DC 6601 separates incapacitating infection episodes from antibiotic-based cough and sputum criteria, and it permits an alternative chronic-bronchitis rating for pulmonary impairment. Bronchiectasis also has a possible one-year chronic-disease presumption, distinct from the PACT Act. A complete record tracks physician-required bed rest, treatment, antibiotic duration, sputum findings, PFTs, and the exact service-connection route.
Related Conditions and Tools
Compare chronic bronchitis, COPD, asthma, and constrictive bronchiolitis. Review DC 6601 and DC 6600, and organize infection and functional evidence with the Statement Builder.
Legal sources: 38 CFR § 4.97, § 4.96, § 3.307, § 3.309, § 3.303, and § 3.310, checked August 17, 2026.